Summary
5 public procurers from 4 countries will procure innovative ICT-enabled monitoring solutions to improve health status and optimise hypertension care. HSMonitor will make person-centred care reality - giving the patient the steering wheel - for optimal health outcomes. The procurers have set a comprehensive framework for requirements and solution design consisting of 9 building blocks in three domains, to be addressed in an integrated ICT-enabled hypertension care solution.
HSmonitor will apply the internationally acclaimed Chronic Care Model to specify support needs for hypertensive patients at all stages. Self-management and treatment will be supported by personalised guidelines and making the best use of clinical data. In this way a quality culture in healthcare will be fostered and learning healthcare systems made reality.
Suppliers will be rigorously evaluated after each of the procurement phases, comprising (I) an open market consultation, (II) specification of architecture and system aligned to requirements of patients, peers and providers, (III) prototype development and testing with end-users and (IV) effectiveness proven in a trial with 500 patients and 150 professionals.
Fully rolled out in the procurer countries, enabled by procurers with the authority and capacity in their countries and regions, HSMonitor will serve 31 million patients with hypertension. Reductions in hypertension-related complications promise cost relief of € 5 billion over 7 years in the five procurer countries. Suppliers can expect a turnover of € 1 billion a year. Proven ability to cover the four different health systems promises HSMonitor suppliers easy entry into other EU markets and beyond, a very strong
contribution to overcoming fragmentation of demand and fostering the global market.
HSmonitor will apply the internationally acclaimed Chronic Care Model to specify support needs for hypertensive patients at all stages. Self-management and treatment will be supported by personalised guidelines and making the best use of clinical data. In this way a quality culture in healthcare will be fostered and learning healthcare systems made reality.
Suppliers will be rigorously evaluated after each of the procurement phases, comprising (I) an open market consultation, (II) specification of architecture and system aligned to requirements of patients, peers and providers, (III) prototype development and testing with end-users and (IV) effectiveness proven in a trial with 500 patients and 150 professionals.
Fully rolled out in the procurer countries, enabled by procurers with the authority and capacity in their countries and regions, HSMonitor will serve 31 million patients with hypertension. Reductions in hypertension-related complications promise cost relief of € 5 billion over 7 years in the five procurer countries. Suppliers can expect a turnover of € 1 billion a year. Proven ability to cover the four different health systems promises HSMonitor suppliers easy entry into other EU markets and beyond, a very strong
contribution to overcoming fragmentation of demand and fostering the global market.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/856698 |
Start date: | 01-10-2019 |
End date: | 30-09-2023 |
Total budget - Public funding: | 6 592 200,00 Euro - 5 932 980,00 Euro |
Cordis data
Original description
5 public procurers from 4 countries will procure innovative ICT-enabled monitoring solutions to improve health status and optimise hypertension care. HSMonitor will make person-centred care reality - giving the patient the steering wheel - for optimal health outcomes. The procurers have set a comprehensive framework for requirements and solution design consisting of 9 building blocks in three domains, to be addressed in an integrated ICT-enabled hypertension care solution.HSmonitor will apply the internationally acclaimed Chronic Care Model to specify support needs for hypertensive patients at all stages. Self-management and treatment will be supported by personalised guidelines and making the best use of clinical data. In this way a quality culture in healthcare will be fostered and learning healthcare systems made reality.
Suppliers will be rigorously evaluated after each of the procurement phases, comprising (I) an open market consultation, (II) specification of architecture and system aligned to requirements of patients, peers and providers, (III) prototype development and testing with end-users and (IV) effectiveness proven in a trial with 500 patients and 150 professionals.
Fully rolled out in the procurer countries, enabled by procurers with the authority and capacity in their countries and regions, HSMonitor will serve 31 million patients with hypertension. Reductions in hypertension-related complications promise cost relief of € 5 billion over 7 years in the five procurer countries. Suppliers can expect a turnover of € 1 billion a year. Proven ability to cover the four different health systems promises HSMonitor suppliers easy entry into other EU markets and beyond, a very strong
contribution to overcoming fragmentation of demand and fostering the global market.
Status
SIGNEDCall topic
SC1-DTH-10-2019-2020Update Date
26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all